These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 88369)

  • 1. Relative effectiveness of spinal cord and purified myelin basic protein in producing resistance to experimental allergic encephalomyelitis.
    McDermott JR; Keith AB
    Eur Neurol; 1979; 18(2):136-9. PubMed ID: 88369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of chronic-relapsing experimental allergic encephalomyelitis in strain-13 guinea pigs by administration of liposome-associated myelin basic protein.
    Strejan GH; Gilbert JJ; St Louis J
    J Neuroimmunol; 1984 Nov; 7(1):27-41. PubMed ID: 6209299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of experimental allergic encephalomyelitis by ganglioside GM4.
    Mullin BR; Patrick DH; Poore CM; Smith MT
    Brain Res; 1984 Mar; 296(1):174-6. PubMed ID: 6201236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal cord neuropathology in rat experimental autoimmune encephalomyelitis: modulation by oral administration of myelin basic protein.
    Popovich PG; Yu JY; Whitacre CC
    J Neuropathol Exp Neurol; 1997 Dec; 56(12):1323-38. PubMed ID: 9413281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapsing experimental allergic encephalomyelitis induced with isolated myelin and with myelin basic protein plus myelin lipids.
    Madrid RE; Wiśniewski HM; Iqbal K; Pullarkat RK; Lassmann H
    J Neurol Sci; 1981 Jun; 50(3):399-411. PubMed ID: 6167679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epicutaneous immunization with myelin basic protein protects from the experimental autoimmune encephalomyelitis.
    Majewska M; Zajac K; Srebro Z; Sura P; Ksiazek L; Zemelka M; Szczepanik M
    Pharmacol Rep; 2007; 59(1):74-9. PubMed ID: 17377209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of resistance to experimental allergic encephalomyelitis in newborn guinea pigs.
    Staykova M; Kozovska M; Kirazjan N; Goranov I
    Neurol Psychiatr (Bucur); 1989; 27(3):225-9. PubMed ID: 2479972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic relapsing experimental autoimmune encephalomyelitis. treatment with combinations of myelin components promotes clinical and structural recovery.
    Traugott U; Stone SH; Raine CS
    J Neurol Sci; 1982 Oct; 56(1):65-73. PubMed ID: 6183403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic progressive experimental allergic encephalomyelitis (EAE) in adult guinea pigs.
    Wisniewski HM; Madrid RE
    J Neuropathol Exp Neurol; 1983 May; 42(3):243-55. PubMed ID: 6188808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of experimental autoimmune encephalomyelitis in rats and immune response to myelin basic protein in lipid-bound form.
    Massacesi L; Vergelli M; Zehetbauer B; Liuzzi GM; Olivotto J; Ballerini C; Uccelli A; Mancardi L; Riccio P; Amaducci L
    J Neurol Sci; 1993 Oct; 119(1):91-8. PubMed ID: 7504090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of experimental allergic encephalomyelitis (EAE) by a rationally designed cyclic analogue of myelin basic protein (MBP) epitope 72-85.
    Tselios T; Daliani I; Deraos S; Thymianou S; Matsoukas E; Troganis A; Gerothanassis I; Mouzaki A; Mavromoustakos T; Probert L; Matsoukas J
    Bioorg Med Chem Lett; 2000 Dec; 10(24):2713-7. PubMed ID: 11133075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit.
    Sun JB; Rask C; Olsson T; Holmgren J; Czerkinsky C
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7196-201. PubMed ID: 8692968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of experimental allergic encephalomyelitis induced with spinal cord, basic protein, and synthetic encephalitogenic peptide.
    Hoffman PM; Gaston DD; Spitler LE
    Clin Immunol Immunopathol; 1973 Apr; 1(3):364-71. PubMed ID: 4127172
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppression of experimental allergic encephalomyelitis in guinea/pigs by liposome-associated human myelin basic protein.
    Strejan GH; Percy DH; St Louis J; Surlan D; Paty DW
    J Immunol; 1981 Nov; 127(5):2064-9. PubMed ID: 6170686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of experimental autoimmune encephalomyelitis in guinea pigs using myelin basic protein and myelin glycolipids.
    Kusunoki S; Yu RK; Kim JH
    J Neuroimmunol; 1988 Jul; 18(4):303-14. PubMed ID: 2454944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein-specific Th2 cell lines generated in the presence of glucocorticoids and IL-4.
    Ramírez F; Mason D
    Eur J Immunol; 2000 Mar; 30(3):747-58. PubMed ID: 10741389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunomorphological characteristics of experimental allergic encephalomyelitis induced by an encephalitogenic polypeptide].
    Zhitnukhin IuL; Khizhniak MG
    Biull Eksp Biol Med; 1987 Mar; 103(3):343-6. PubMed ID: 2435338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental allergic encephalomyelitis (EAE) in mice. I. Induction of EAE with mouse spinal cord homogenate and myelin basic protein.
    Yasuda T; Tsumita T; Nagai Y; Mitsuzawa E; Ohtani S
    Jpn J Exp Med; 1975 Oct; 45(5):423-7. PubMed ID: 57253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Durability of immune protection against experimental autoimmune encephalomyelitis.
    Bernard CC; Mackay IR; Whittingham S; Brous P
    Cell Immunol; 1976 Mar; 22(2):297-310. PubMed ID: 58731
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental autoimmune encephalomyelitis. Augmentation of demyelination by different myelin lipids.
    Moore GR; Traugott U; Farooq M; Norton WT; Raine CS
    Lab Invest; 1984 Oct; 51(4):416-24. PubMed ID: 6207382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.